Exploring Spatial Heterogeneity of Immune Cells in Nasopharyngeal Cancer.

biomarker discovery digital spatial profiling immune cells immune phenotypes nasopharyngeal cancer spatial omics

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
05 Apr 2023
Historique:
received: 28 02 2023
revised: 31 03 2023
accepted: 04 04 2023
medline: 14 4 2023
entrez: 13 4 2023
pubmed: 14 4 2023
Statut: epublish

Résumé

Nasopharyngeal cancer (NPC) is a malignant tumor. In a recent publication, we described the presence and distribution of CD8

Identifiants

pubmed: 37046826
pii: cancers15072165
doi: 10.3390/cancers15072165
pmc: PMC10093565
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : EU Horizon 2020 Framework programme for research and innovation
ID : EU-MSCACOFUND, 754299, CanFaster
Organisme : Cancera Foundation
ID : no grant number
Organisme : Mrs. Bertha Kamprad's Research Foundation
ID : no grant number
Organisme : Henning and Ida Persson's Research Foundation
ID : no grant number

Références

J Cancer Res Ther. 2018 Jun;14(Supplement):S331-S335
pubmed: 29970685
Mol Cancer Res. 2017 Dec;15(12):1722-1732
pubmed: 28851814
Lancet. 2019 Jul 6;394(10192):64-80
pubmed: 31178151
Cancer Manag Res. 2018 Jul 09;10:1935-1946
pubmed: 30022852
J Clin Pathol. 2018 Mar;71(3):267-274
pubmed: 28877959
Diagnostics (Basel). 2021 Mar 31;11(4):
pubmed: 33807310
Oncol Lett. 2019 Feb;17(2):2557-2561
pubmed: 30719121
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820909911
pubmed: 32281480
J Immunother Cancer. 2019 Nov 13;7(1):298
pubmed: 31722750
J Immunother Cancer. 2020 Apr;8(1):
pubmed: 32303611
Oral Oncol. 2017 Aug;71:16-25
pubmed: 28688685
Lancet Oncol. 2021 Aug;22(8):1162-1174
pubmed: 34174189
J Immunother Cancer. 2020 Jul;8(2):
pubmed: 32690665
Cell. 2021 Feb 4;184(3):792-809.e23
pubmed: 33545035
Cancer Med. 2022 Nov;11(22):4310-4320
pubmed: 35475595
Cell Res. 2020 Nov;30(11):950-965
pubmed: 32901110
Int J Clin Exp Pathol. 2017 Aug 01;10(8):8389-8401
pubmed: 31966691
Cell Res. 2020 Nov;30(11):1024-1042
pubmed: 32686767
Clin Cancer Res. 2018 Jun 1;24(11):2653-2664
pubmed: 29530936
Cancers (Basel). 2020 Nov 18;12(11):
pubmed: 33218184
Biomed Pharmacother. 2019 Jan;109:1772-1784
pubmed: 30551431
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Clin Cancer Res. 2019 Jun 1;25(11):3220-3228
pubmed: 30770348
Head Neck. 2018 Sep;40(9):2007-2019
pubmed: 29756253
Front Oncol. 2022 Jun 29;12:890410
pubmed: 35847846
Cancer Res. 2001 Feb 1;61(3):1100-6
pubmed: 11221839
Adv Exp Med Biol. 2019;1164:11-34
pubmed: 31576537
Int J Cancer. 2018 Jun 15;142(12):2558-2566
pubmed: 29377121
Nat Commun. 2021 Mar 9;12(1):1540
pubmed: 33750785
mSystems. 2018 Sep 25;3(5):
pubmed: 30271878
Nat Commun. 2021 Feb 2;12(1):741
pubmed: 33531485
Cancers (Basel). 2018 Apr 04;10(4):
pubmed: 29617291
Semin Cancer Biol. 2020 Apr;61:84-100
pubmed: 31521748
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Tumour Biol. 2014 Feb;35(2):1703-12
pubmed: 24081675
J Hematol Oncol. 2020 Jun 29;13(1):83
pubmed: 32600443

Auteurs

Aastha Sobti (A)

Department of Immunotechnology, Lund University, 223 81 Lund, Sweden.

Christina Sakellariou (C)

Department of Immunotechnology, Lund University, 223 81 Lund, Sweden.

Johan S Nilsson (JS)

Department of ORL, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.
Department Clinical Sciences, Lund University, 221 00 Lund, Sweden.

David Askmyr (D)

Department of ORL, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.
Department Clinical Sciences, Lund University, 221 00 Lund, Sweden.

Lennart Greiff (L)

Department of ORL, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.
Department Clinical Sciences, Lund University, 221 00 Lund, Sweden.

Malin Lindstedt (M)

Department of Immunotechnology, Lund University, 223 81 Lund, Sweden.

Classifications MeSH